Severe rhabdomyolysis induced by a retard formulation of bezafibrate in a CAPD patient

Nephron. 1996;73(4):736. doi: 10.1159/000189184.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Bezafibrate / administration & dosage
  • Bezafibrate / adverse effects*
  • Delayed-Action Preparations
  • Female
  • Humans
  • Hypolipidemic Agents / administration & dosage
  • Hypolipidemic Agents / adverse effects*
  • Middle Aged
  • Peritoneal Dialysis, Continuous Ambulatory / adverse effects*
  • Polycystic Kidney Diseases / complications
  • Polycystic Kidney Diseases / therapy
  • Rhabdomyolysis / chemically induced*

Substances

  • Delayed-Action Preparations
  • Hypolipidemic Agents
  • Bezafibrate